Andreas Schafer
Overview
Explore the profile of Andreas Schafer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
247
Citations
3989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hess A, Renko A, Schafer A, Jung M, Fraccarollo D, Schmitto J, et al.
Mol Imaging Biol
. 2025 Mar;
PMID: 40029570
Purpose: Myocardial infarction (MI) triggers complex cellular responses essential for tissue repair and remodeling, including myofibroblast activation. Fibroblast activation protein alpha (FAP) identifies activated myofibroblasts post-MI, however its spatial distribution...
2.
Grundmann D, Kim W, Kellner C, Adam M, Braun D, Tamm A, et al.
EuroIntervention
. 2025 Mar;
21(5):e272-e281.
PMID: 40028729
Background: Vascular access site complications are associated with increased morbidity and mortality after transcatheter aortic valve implantation (TAVI). Current results comparing strategies with plug- (P-VCD; MANTA) and suture-based vascular closure...
3.
Wilke T, Hussain E, Spallek H, Terlizzi F, Mir L, Bischoff P, et al.
Radiol Oncol
. 2025 Feb;
59(1):100-109.
PMID: 40014781
Background: Electrochemotherapy (ECT) is a local nonsurgical effective tumor treatment in the hand of the clinician for the treatment of patients with liver tumors or metastases. The study aimed to...
4.
Stadlbauer A, Verbelen T, Binzenhofer L, Goslar T, Supady A, Spieth P, et al.
Intensive Care Med
. 2025 Feb;
PMID: 39998658
Background: High-risk acute pulmonary embolism (PE) is a life-threatening condition necessitating hemodynamic stabilization and rapid restoration of pulmonary perfusion. In this context, evidence regarding the benefit of advanced circulatory support...
5.
Poyanmehr R, Hanke J, Boethig D, Merzah A, Karsten J, Frank P, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e012154.
PMID: 39831321
Background: Consensus regarding on-support evaluation and weaning concepts from Impella 5.5 support is scarce. The derived left ventricular end-diastolic pressure (dLVEDP), estimated by device algorithms, is a rarely reported tool...
6.
Schafer A, Alasnag M, Giacoppo D, Collet C, Rudolph T, Roguin A, et al.
EuroIntervention
. 2025 Jan;
21(1):22-34.
PMID: 39773827
This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to...
7.
Grundmann D, Kim W, Kellner C, Adam M, Braun D, Tamm A, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(24):2923-2932.
PMID: 39722273
Background: Transradial secondary access (TR-SA) may serve as an alternative to the traditional femoral secondary access (TF-SA) for pigtail placement in transcatheter aortic valve replacement (TAVR). Objectives: The aim of...
8.
Klein A, Beske R, Hassager C, Jensen L, Eiskjaer H, Mangner N, et al.
J Am Coll Cardiol
. 2024 Nov;
85(6):595-603.
PMID: 39551167
Background: Whether age impacts the recently demonstrated survival benefit of microaxial flow pump (mAFP) treatment in patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock (CS) is unknown. Objectives:...
9.
Schweigerdt A, Stobener D, Scholz J, Schafer A, Weinhart M
ACS Appl Bio Mater
. 2024 Nov;
7(11):7544-7555.
PMID: 39499587
Thermoresponsive polymer coatings on cell culture substrates enable noninvasive cell detachment and cell sheet fabrication for biomedical applications. Optimized coatings should support controlled culture and detachment of various cell types...
10.
Zweck E, Hassager C, Beske R, Jensen L, Eiskjaer H, Mangner N, et al.
Circulation
. 2024 Oct;
150(25):1990-2003.
PMID: 39462276
Background: In DanGer Shock (the Danish-German Cardiogenic Shock trial), use of a microaxial flow pump (mAFP) in patients with ST-segment-elevation myocardial infarction-related cardiogenic shock led to lower all-cause mortality but...